INTCHAINS GROUP LTD-ADR (ICG) Fundamental Analysis & Valuation

NASDAQ:ICG • US45828E1047

Current stock price

1.34 USD
+0.02 (+1.52%)
Last:

This ICG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ICG Profitability Analysis

1.1 Basic Checks

  • In the past year ICG was profitable.
  • In the past year ICG has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ICG reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of ICG (-4.66%) is worse than 63.48% of its industry peers.
  • ICG has a Return On Equity of -4.87%. This is in the lower half of the industry: ICG underperforms 60.87% of its industry peers.
Industry RankSector Rank
ROA -4.66%
ROE -4.87%
ROIC N/A
ROA(3y)-0.89%
ROA(5y)21.65%
ROE(3y)-0.87%
ROE(5y)22.65%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • ICG has a Gross Margin of 7.23%. This is amonst the worse of the industry: ICG underperforms 86.09% of its industry peers.
  • In the last couple of years the Gross Margin of ICG has declined.
  • The Profit Margin and Operating Margin are not available for ICG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-55.43%
GM growth 5Y-33.91%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ICG Health Analysis

2.1 Basic Checks

  • ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ICG has more shares outstanding
  • ICG has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 9.13 indicates that ICG is not in any danger for bankruptcy at the moment.
  • ICG has a Altman-Z score of 9.13. This is in the better half of the industry: ICG outperforms 60.87% of its industry peers.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.13
ROIC/WACCN/A
WACC11.41%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 14.10 indicates that ICG has no problem at all paying its short term obligations.
  • ICG has a better Current ratio (14.10) than 95.65% of its industry peers.
  • ICG has a Quick Ratio of 12.88. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 12.88, ICG belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.1
Quick Ratio 12.88
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ICG Growth Analysis

3.1 Past

  • The earnings per share for ICG have decreased strongly by -46.15% in the last year.
  • ICG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.40%.
  • ICG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.25% yearly.
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y-22.46%
Revenue growth 5Y32.25%
Sales Q2Q%-49.15%

3.2 Future

  • Based on estimates for the next years, ICG will show a very negative growth in Earnings Per Share. The EPS will decrease by -50.08% on average per year.
  • The Revenue is expected to decrease by -1.94% on average over the next years.
EPS Next Y23.67%
EPS Next 2Y-50.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.62%
Revenue Next 2Y-1.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.05 0.1

More info and screens

Find the best growth stocksShow best growing peers

0

4. ICG Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 134.00 indicates a quite expensive valuation of ICG.
  • ICG's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of ICG to the average of the S&P500 Index (27.42), we can say ICG is valued expensively.
  • With a Price/Forward Earnings ratio of 105.82, ICG can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, ICG is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
  • ICG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.29.
Industry RankSector Rank
PE 134
Fwd PE 105.82
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICG does not grow enough to justify the current Price/Earnings ratio.
  • A cheap valuation may be justified as ICG's earnings are expected to decrease with -50.08% in the coming years.
PEG (NY)5.66
PEG (5Y)N/A
EPS Next 2Y-50.08%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICG Dividend Analysis

5.1 Amount

  • ICG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICG Fundamentals: All Metrics, Ratios and Statistics

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (4/27/2026, 12:45:50 PM)

1.34

+0.02 (+1.52%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners0.51%
Inst Owner Change-4.97%
Ins OwnersN/A
Ins Owner Change0%
Market Cap80.90M
Revenue(TTM)220.86M
Net Income(TTM)-47.53M
Analysts80
Price Target3.06 (128.36%)
Short Float %0.76%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-702.37%
Min EPS beat(2)-2912.47%
Max EPS beat(2)1507.72%
EPS beat(4)2
Avg EPS beat(4)-374.63%
Min EPS beat(4)-2912.47%
Max EPS beat(4)1507.72%
EPS beat(8)3
Avg EPS beat(8)-191.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-49.07%
Min Revenue beat(2)-83%
Max Revenue beat(2)-15.14%
Revenue beat(4)1
Avg Revenue beat(4)-36.89%
Min Revenue beat(4)-83%
Max Revenue beat(4)9.68%
Revenue beat(8)2
Avg Revenue beat(8)-23.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-14.29%
EPS NQ rev (1m)-18.6%
EPS NQ rev (3m)-334.04%
EPS NY rev (1m)-14.89%
EPS NY rev (3m)-14.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-34.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.55%
Valuation
Industry RankSector Rank
PE 134
Fwd PE 105.82
P/S 2.5
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)0.01
EY0.75%
EPS(NY)0.01
Fwd EY0.94%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.54
BVpS2.37
TBVpS2.34
PEG (NY)5.66
PEG (5Y)N/A
Graham Number0.729645 (-45.55%)
Profitability
Industry RankSector Rank
ROA -4.66%
ROE -4.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.23%
FCFM N/A
ROA(3y)-0.89%
ROA(5y)21.65%
ROE(3y)-0.87%
ROE(5y)22.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-55.43%
GM growth 5Y-33.91%
F-Score2
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.64%
Cap/Sales 2.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.1
Quick Ratio 12.88
Altman-Z 9.13
F-Score2
WACC11.41%
ROIC/WACCN/A
Cap/Depr(3y)533.26%
Cap/Depr(5y)424.4%
Cap/Sales(3y)22.45%
Cap/Sales(5y)13.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
EPS Next Y23.67%
EPS Next 2Y-50.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y-22.46%
Revenue growth 5Y32.25%
Sales Q2Q%-49.15%
Revenue Next Year48.62%
Revenue Next 2Y-1.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-522.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.78%
OCF growth 3YN/A
OCF growth 5YN/A

INTCHAINS GROUP LTD-ADR / ICG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTCHAINS GROUP LTD-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to ICG.


What is the valuation status for ICG stock?

ChartMill assigns a valuation rating of 0 / 10 to INTCHAINS GROUP LTD-ADR (ICG). This can be considered as Overvalued.


How profitable is INTCHAINS GROUP LTD-ADR (ICG) stock?

INTCHAINS GROUP LTD-ADR (ICG) has a profitability rating of 1 / 10.


What is the financial health of INTCHAINS GROUP LTD-ADR (ICG) stock?

The financial health rating of INTCHAINS GROUP LTD-ADR (ICG) is 8 / 10.


Can you provide the expected EPS growth for ICG stock?

The Earnings per Share (EPS) of INTCHAINS GROUP LTD-ADR (ICG) is expected to grow by 23.67% in the next year.